Table 1 Patient characteristics across TAPSE/TRV tertiles

TAPSE/TRV ratio

4.73 (3.81, 5.38)

6.92 (6.44, 7.46)

9.78 (8.83, 11.04)

Age (years)

73 (64, 79)

70 (60, 78)

63 (52, 73)

Sex

 Female

189 (53%)

191 (53%)

191 (53%)

 Male

170 (47%)

168 (47%)

168 (47%)

APACHE 3 score

72 (58, 88)

65 (51, 86)

62 (46, 80)

(Missing)

12

11

5

Medical/Surgical

 Medical

322 (90%)

314 (87%)

298 (83%)

 Surgical

37 (10%)

45 (13%)

61 (17%)

Invasive ventilation

 Not ventilated

187 (52%)

180 (50%)

174 (48%)

 Ventilated

172 (48%)

179 (50%)

185 (52%)

APACHE comorbidities

 Cirrhosis

10 (2.8%)

12 (3.3%)

13 (3.6%)

 Chronic respiratory disease

62 (17%)

48 (13%)

38 (11%)

 Chronic cardiovascular disease

45 (13%)

26 (7.2%)

5 (1.4%)

 Chronic renal disease

18 (5.0%)

18 (5.0%)

7 (1.9%)

 Immunosuppressed

57 (16%)

64 (18%)

47 (13%)

 Hepatic failure

2 (0.6%)

1 (0.3%)

0 (0%)

 Metastatic cancer

9 (2.5%)

13 (3.6%)

13 (3.6%)

ICU length of stay (days)

3.7 (2.1, 7.2)

3.8 (2.1, 7.0)

3.8 (1.9, 7.9)

ICU outcome

 Died

71 (20%)

58 (16%)

41 (11%)

 Survived

288 (80%)

301 (84%)

318 (89%)

Hospital length of stay (days)

12 (6, 22)

11 (6, 22)

11 (6, 27)

(Missing)

2

6

1

Hospital outcome

 Died

109 (30%)

83 (23%)

59 (16%)

 Survived

249 (70%)

274 (77%)

300 (84%)

 (Missing)

1

2

0

Long-term outcome

 Dead

253 (70%)

207 (58%)

159 (44%)

 Survived

106 (30%)

152 (42%)

200 (56%)